Subclinical Cushing's syndrome is a potential cause of metabolic dementia and rapidly progressive Alzheimer-type dementia

Medical Hypotheses

Volumn 71, Issue 5, 2008, Pages 703-705

  Guldiken, Sibel ^a   Guldiken, Baburhan ^a  

^a TRAKYA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE;

ALZHEIMER DISEASE; ARTICLE; CUSHING SYNDROME; DEMENTIA; DISEASE ASSOCIATION; DISEASE COURSE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERCORTISOLISM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MENTAL DISEASE; MOOD CHANGE; PREVALENCE; PRIORITY JOURNAL;

ALZHEIMER DISEASE; COGNITION DISORDERS; CUSHING SYNDROME; DEMENTIA; DISEASE PROGRESSION; HIPPOCAMPUS; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MODELS, BIOLOGICAL; MODELS, THEORETICAL; PITUITARY-ADRENAL SYSTEM;

EID: 52949091502     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2008.05.036     Document Type: Article

References (23)

1. Pivonello R., De Martino M.C., De Leo M., Lombardi G., and Colao A. Cushing's syndrome. Endocrinol Metab Clin North Am 37 (2008) 135-149
2. Kelly W.F. Psychiatric aspects of Cushing's syndrome. QJM 89 (1996) 543-551
3. Forget H., Lacroix A., Somma M., and Cohen H. Cognitive decline in patients with Cushing's syndrome. J Int Neuropsychol Soc 6 (2000) 20-29
4. Reul J.M., and de Kloet E.R. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 117 (1985) 2505-2511
5. Reul J.M., Gesing A., Droste S., et al. The brain mineralocorticoid receptor: greedy for ligand, mysterious in function. Eur J Pharmacol 405 (2000) 235-249
6. De Kloet E.R., Vreugdenhil E., Oitzl M.S., and Joëls M. Brain corticosteroid receptor balance in health and disease. Endocr Rev 19 (1998) 269-301
7. Lupien S.J., and McEwen B.S. The acute effects of corticosteroids on cognition: integration of animal and human model studies. Brain Res Brain Res Rev 24 (1997) 1-27
8. Sousa N., and Almeida O.F. Corticosteroids: sculptors of the hippocampal formation. Rev Neurosci 13 (2002) 59-84
9. American psychiatric association diagnostic and statistical manual, 4th ed., Washington DC: APA Press; 1994.
10. Knopman D.S., Boeve B.F., and Petersen R.C. Essentials of the proper diagnoses of mild cognitive impairment, dementia, and major subtypes of dementia. Mayo Clin Proc 78 (2003) 1290-1308
11. Patterson C., Feightner J.W., Garcia A., Hsiung G.Y., MacKnight C., and Sadovnick A.D. Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease. CMAJ 178 (2008) 548-556
12. Reincke M. Subclinical Cushing's syndrome. Endocrinol Metab Clin North Am 29 (2000) 43-56
13. Mantero F., Terzolo M., Arnaldi G., et al. A survey on adrenal incidentaloma in Italy. Study group on adrenal tumors of the Italian society of endocrinology. J Clin Endocrinol Metab 85 (2000) 637-644
14. Rossi R., Tauchmanova L., Luciano A., et al. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features. J Clin Endocrinol Metab. 85 (2000) 1440-1448
15. Csernansky J.G., Dong H., Fagan A.M., et al. Plasma cortisol and progression of dementia in subjects with Alzheimer-type dementia. Am J Psychiatry 163 (2006) 2164-2169
16. Terzolo M., Osella G., Ali A., et al. Subclinical Cushing's syndrome in adrenal incidentaloma. Clin Endocrinol 48 (1998) 89-97
17. Jacobson L., and Sapolsky R. The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis. Endocr Rev 12 (1991) 118-134
18. Tessner K.D., Walker E.F., Dhruv S.H., Hochman K., and Hamann S. The relation of cortisol levels with hippocampus volumes under baseline and challenge conditions. Brain Res 1179 (2007) 70-78
19. Bourdeau I., Bard C., Noël B., et al. Loss of brain volume in endogenous Cushing's syndrome and its reversibility after correction of hypercortisolism. J Clin Endocrinol Metab 87 (2002) 1949-1954
20. Kole M.H., Czéh B., and Fuchs E. Homeostatic maintenance in excitability of tree shrew hippocampal CA3 pyramidal neurons after chronic stress. Hippocampus 14 (2004) 742-751
21. Dai J., Buijs R., and Swaab D. Glucocorticoid hormone (cortisol) affects axonal transport in human cortex neurons but shows resistance in Alzheimer's disease. Br J Pharmacol 143 (2004) 606-610
22. Peskind E.R., Wilkinson C.W., Petrie E.C., Schellenberg G.D., and Raskind M.A. Increased CSF cortisol in AD is a function of APOE genotype. Neurology 56 (2001) 1094-1098
23. de Quervain D.J., Poirier R., Wollmer M.A., et al. Glucocorticoid-related genetic susceptibility for Alzheimer's disease. Hum Mol Genet 13 (2004) 47-52